Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Efficacy and Safety of Temporal Interference Stimulation on Cognitive Function in Patients With Early-Stage Alzheimer's Disease [NA]
A clinical trial is evaluating the efficacy and safety of temporal interference stimulation for cognitive function in patients with early-st…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease [Phase 1]
A Phase 1 clinical trial is evaluating PET imaging of cyclooxygenases in neurodegenerative brain diseases, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
A prospective observational study examining how sociodemographic factors, blood-based biomarkers, and psychiatric symptoms relate across sev…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) [Phase 1]
Phase 1 clinical trial update evaluating a PET imaging agent targeting phosphodiesterase-4 (PDE4) in volunteers including individuals with A…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease [Phase 1]
A Phase 1 clinical trial evaluating ALN-5288 in patients with Alzheimer's disease is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: The Brain&Senses Study
The Brain&Senses Study is an active but not recruiting clinical trial sponsored by the University of Campania Luigi Vanvitelli, investigatin…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease [Phase 4]
This clinical trial update describes a Phase 4 study of daridorexant for insomnia in patients with mild cognitive impairment and Alzheimer's…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia [NA]
This clinical trial evaluates the efficacy and safety of ATNC-MDD V1, a transcranial magnetic stimulation (TMS) with cognitive training, for…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease [Phase 2, Phase 3]
Clinical trial update indicating that Actinogen Medical's Xanamem (10 mg) is being studied for dementia related to Alzheimer's disease in Ph…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2) [Phase 3]
Phase 3 clinical trial ADAGIO-2 is evaluating the safety and efficacy of KarXT plus KarX-EC for agitation in Alzheimer's disease and is curr…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Retinal Hyperspectral Imaging in Neurodegenerative Diseases [NA]
A clinical trial is investigating retinal hyperspectral imaging for neurodegenerative diseases and dementia, currently recruiting participan…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1) [Phase 3]
A Phase 3 clinical trial (ADEPT-1, NCT05511363) evaluating KarXT for psychosis associated with Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) [Phase 3]
A Phase 3 clinical trial is evaluating the safety and efficacy of KarXT plus KarX-EC for agitation in Alzheimer's disease, and the study is …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia [NA]
A protocol study evaluating multifocal transcranial direct current stimulation (tDCS) with EEG monitoring to improve symptoms in mild cognit…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Randomized Controlld Trial of Dementia Education Resources for Action [NA]
A randomized controlled trial evaluating dementia education resources for action is registered; recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology [NA]
This is a clinical trial status update for an amyloid monoclonal antibody treatment in Parkinson disease patients with coexistent Alzheimer'…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study [Phase 1]
Phase 1 pilot clinical trial evaluating faecal microbiota transplantation for Alzheimer’s disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5) [Phase 3]
Phase 3 ADEPT-5 is evaluating the safety and efficacy of KarXT plus KarX-EC for psychosis associated with Alzheimer's disease; the trial is …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
Postmarketing study of LEQEMBI (lecanemab) in South Korean participants with Alzheimer's disease. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: The Nightlight Falls Prevention Study [NA]
The Nightlight Falls Prevention Study is currently enrolling by invitation, led by the University of North Carolina, Chapel Hill, investigat…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) [Phase 3]
This ClinicalTrials.gov entry describes a Phase 3 study evaluating the long-term efficacy and safety of KarXT plus KarX-EC for agitation in …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients [NA]
Update on the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet trial in stroke patients. The study is currently activ…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Stem Cell Therapy for Early Alzheimer's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial is recruiting to evaluate a stem cell therapy for early Alzheimer's disease.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease [Phase 1]
This is a first-in-human Phase 1 study of LY3954068 in adults with early symptomatic Alzheimer's disease, and it is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia [NA]
Stanford University is conducting a study examining sleep disturbance and emotion regulation brain dysfunction as potential mechanisms for n…